BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust

BMEZ

$17.34

Updated: 03/11/2026, 13:40:26

Market Cap
$1.76B
Sector
Financial Services
Industry
Asset Management
Country
US

No historical data available

Company Profile

BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.

USD
NYSE
CEO: John Perlowski
https://www.blackrock.com
Asset Summaries
Latest generated summaries for BMEZ

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BMEZ.
Share price
$17.34
Market cap
$1.76B
Exchange
NYSE
Currency
USD
CEO
John Perlowski
Employees
N/A
IPO date
29/01/2020
Beta
0.864
Last dividend
$0.00
Day range
$17.32 – $17.70
52-week range
$13.70 – $17.96
1-day performance
-1.22%
1-year performance
26.57%
Current drawdown (1Y)
-3.45%
CIK
0001785971
CUSIP
09260E105
ISIN
US09260E1055
Created
07/12/2025, 03:03:03
Last update
03/11/2026, 13:40:26

Track BlackRock Health Sciences Term Trust with an AI analyst

See which prediction-market events move BMEZ, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.